Aspirin: New Insights Into Its Mechanism of Interaction With Cancer
/in Drug repurposing, Preclinical Research/by MaxZebrafish Embryo miRNAs: A Potential New Approach to Slow or Stop Cancer Spread
/in Not PCa related, Preclinical Research/by MaxNewsletter 22/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! Summer is approaching (ok, apologies to our friends from down under), but research doesn’t stop! Once again this week, we’ve got major updates on clinical trials—and just one preclinical study, but it’s been carefully selected just for you! Stay […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy CAR-T clinical trial clinical trials crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide EZH2 inhibitor HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Newsletter 48/2025 November 30, 2025
- Phase 1/2 Trial for MK-6070: A Promising Trispecific T-Cell Engager for Neuroendocrine Cancers November 29, 2025
- UPDATE: Phase 1 GenSci143 Trial Set To Start By The End of December November 27, 2025
- Phase 2 Trial for The Combo Fasudil Hydrochloride Plus PD-1 Immune Checkpoint Blockade November 27, 2025